All Stories

  1. FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer

    Article • British Journal of Cancer, November 2019, Springer Science + Business Media

    Lana McClements

  2. Service evaluation of diabetes management during pregnancy in a regional maternity hospital: potential scope for increased self-management and remote patient monitoring through mHealth solutions

    Article • BMC Health Services Research, September 2019, Springer Science + Business Media

    Lana McClements

  3. Association between Galectin-3 levels within central and peripheral venous blood, and adverse left ventricular remodelling after first acute myocardial infarction

    Article • Scientific Reports, September 2019, Springer Science + Business Media

    Lana McClements

  4. Association of Nrf2, SOD2 and GPX1 Polymorphisms with Biomarkers of Oxidative Distress and Survival in End-Stage Renal Disease Patients

    Article • Toxins, July 2019, MDPI AG

    Lana McClements

  5. FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4

    Article • BMC Cancer, April 2019, Springer Science + Business Media

    Lana McClements

  6. Hypercapnic acidosis induces mitochondrial dysfunction and impairs the ability of mesenchymal stem cells to promote distal lung epithelial repair

    Article • The FASEB Journal, April 2019, Federation of American Societies For Experimental Biology (FASEB)

    Dr Anna Krasnodembskaya, Lana McClements, Nicola Fergie

  7. Markers of Oxidative Stress and Endothelial Dysfunction Predict Haemodialysis Patients Survival

    Article • American Journal of Nephrology, January 2019, Karger Publishers

    Lana McClements

  8. Engaging hard-to-reach populations in research on health in pregnancy: the value of Boal’s simultaneous dramaturgy

    Article • Arts & Health, December 2018, Taylor & Francis

    Lana McClements

  9. Risk of pre-eclampsia in women taking metformin: a systematic review and meta-analysis

    Article • Diabetic Medicine, January 2018, Wiley

    Lana McClements

  10. Elucidating the Pathogenesis of Pre-eclampsia Using In Vitro Models of Spiral Uterine Artery Remodelling

    Article • Current Hypertension Reports, October 2017, Springer Science + Business Media

    Lana McClements

  11. The Role of Peptidyl Prolyl Isomerases in Aging and Vascular Diseases

    Article • Current Molecular Pharmacology, December 2015, Bentham Science Publishers

    Lana McClements

  12. RALA-mediated delivery of FKBPL nucleic acid therapeutics

    Article • Nanomedicine, October 2015, Future Medicine

    Lana McClements

  13. FKBPL: a marker of good prognosis in breast cancer

    Article • Oncotarget, April 2015, Impact Journals, LLC

    Lana McClements

  14. FKBPL Is a Critical Antiangiogenic Regulator of Developmental and Pathological Angiogenesis

    Article • Arteriosclerosis Thrombosis and Vascular Biology, April 2015, Wolters Kluwer Health

    Lana McClements

  15. Identification of RBCK1 as a novel regulator of FKBPL: implications for tumor growth and response to tamoxifen

    Article • Oncogene, August 2013, Springer Science + Business Media

    Lana McClements

  16. Targeting Treatment-Resistant Breast Cancer Stem Cells with FKBPL and Its Peptide Derivative, AD-01, via the CD44 Pathway

    Article • Clinical Cancer Research, June 2013, American Association for Cancer Research (AACR)

    Lana McClements

  17. The Anti-Migratory Effects of FKBPL and Its Peptide Derivative, AD-01: Regulation of CD44 and the Cytoskeletal Pathway

    Article • PLoS ONE, February 2013, PLOS

    Lana McClements